Understanding Test Results

Size: px
Start display at page:

Download "Understanding Test Results"

Transcription

1 Understanding Test Results 8 th Annual Metastatic Breast Cancer Conference September 20-21, 2014 Friday Center Chapel Hill NC Delma Armstrong, BSN, RN, OCN Nurse Navigator, UNC Breast Program

2 Types of Tests Laboratory tests on blood samples Laboratory tests on tumor tissue samples Imaging X-rays CT Scans MRI Scans Nuclear Medicine Scans

3 What are the costs of tests? $24,000 question Monetary costs can be high Insurance reimbursement can vary widely, even when ordered by the same provider, in different settings Psychological costs can also be high - Anxiety Abnormal test results may lead to more tests Additional abnormal results may lead to even more tests and/or procedures such as biopsies.

4 What are tests for? In Metastatic Breast Cancer (MBC), periodic testing is done To MONITOR disease activity To MONITOR treatment effect To INFORM treatment decisions

5 Blood Tests Chemistries Tumor Markers Liver Enzymes Sodium, Potassium BUN, Creatinine Calcium, Phosphorus Glucose CA 15.3 CA CA 125 CEA (carcinoembryonic antigen)

6 Blood Chemistries Indirectly give information on organ function Checked periodically to assess risk of treatment side effects Tests checked may depend on location of metastases and/or side effects of treatments Liver Enzymes check liver function Sodium, Potassium check hydration, liver and kidney function BUN, Creatinine check kidney function Calcium, Phosphorus check bone health Glucose check for diabetes

7 Tumor Markers in Blood Advantages Can be early indicators of disease progression Can assist in therapy decisions Are checked periodically to check response to ongoing treatment Disadvantages Not conclusive Negative result no cancer Positive result growing cancer

8 Tumor Markers in Blood Used in MBC to monitor response to therapy Decreasing tumor marker = treatment working Can help avoid costly imaging studies Increasing tumor marker not as clear MUST be used with other indicators of disease process: Physical Exam, Labs, Scans, history

9 Tumor Markers in Blood Best tests for Breast Cancer CA 15.3 CA CA 125 CEA (carcinoembryonic antigen)

10 Tumor Markers in Tissue ImmunoHistoChemistry tests ER (estrogen receptor) PR (progesterone receptor) Her2 (her2neu oncogene) FISH (Fluorescence InSitu Hybridization) Quantifies Her2, especially when IHC borderline

11 Tumor Markers in Tissue Guide treatment with targeted therapies Biologic Agents Decrease the effect of Her2neu oncogene Used when Her2neu is 3+ or overamplified Herceptin (trastuzumab) Tykerb (lapatinib) Perjeta (pertuzumab) Hormone Therapy can block estrogen/progesterone receptors slowing tumor growth

12 Imaging X-rays Bone density scan CT Scans MRI Scans Nuclear Medicine Scans Bone Scans PET Scans

13 Imaging X-rays Bone Density Scan

14 CT Scan Imaging

15 MRI Scan Imaging

16 NM Bone Scan Imaging

17 PET/CT Scan Imaging

18 Imaging Comparison Test Cost Advantage Disadvantage Limitations X-ray $ Quick, easy Radiation exposure Structures overlap CT $$ Quick, easy No structure overlap MRI $$$ Shows tissues well No radiation Contrast not likely to cause allergy Bone Scan SS Very sensitive for bone lesions PET $$$$ Identifies cancer affected areas PET,CT PET/MRI $$$$$ Combines advantaes of each More radiation IV contrast needed Studies take longer Requires IV contrast Size matters Radiation exposture Requires IV contrast Takes several hours Radiation exposure Images not detailed Radiation, Contrast, Takes a long time Positioning Must lie flat IV access Allergy? Must lie still Must lie flat IV access Claustrophobia IV access Must lie still IV access Must lie still Blood glucose must be normal

19 Test Results What is the purpose of the test? How accurate is the test? Advantages/disadvantages How long will it take? When will we know results? How will I get my result? What is the plan if result is negative? What is the plan if result is positive?

20

Neoplasia 2018 lecture 11. Dr H Awad FRCPath

Neoplasia 2018 lecture 11. Dr H Awad FRCPath Neoplasia 2018 lecture 11 Dr H Awad FRCPath Clinical aspects of neoplasia Tumors affect patients by: 1. their location 2. hormonal secretions 3. paraneoplastic syndromes 4. cachexia Tumor location Even

More information

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment?

Breast Cancer. Excess Estrogen Exposure. Alcohol use + Pytoestrogens? Abortion. Infertility treatment? Breast Cancer Breast Cancer Excess Estrogen Exposure Nulliparity or late pregnancy + Early menarche + Late menopause + Cystic ovarian disease + External estrogens exposure + Breast Cancer Excess Estrogen

More information

My Personalized Breast Cancer Worksheet

My Personalized Breast Cancer Worksheet My Personalized Breast Cancer Worksheet KNOW For Early-Stage Breast Cancer. No Questions. Only Results. No two tumors are alike. What are the characteristics of your breast cancer and how will that effect

More information

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine

What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Layman s terms: cancer starts when cells grow out of control (in any place in the body) and crowd out normal cells

More information

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.

Case Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions. Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to

More information

Breast Cancer Diagnosis, Treatment and Follow-up

Breast Cancer Diagnosis, Treatment and Follow-up Breast Cancer Diagnosis, Treatment and Follow-up What is breast cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide to produce

More information

Kaiser Permanente 2015 Sample Fee List 1

Kaiser Permanente 2015 Sample Fee List 1 Kaiser Permanente 2015 Sample Fee List 1 SOUTHERN CALIFORNIA Knowing how much you can expect to pay for care and services can give you peace of mind. This Sample Fee List shows you estimated charges for

More information

Kaiser Permanente 2012 Sample Fee List Members in any deductible plan 1 can use this list to help estimate their charges.

Kaiser Permanente 2012 Sample Fee List Members in any deductible plan 1 can use this list to help estimate their charges. Kaiser Permanente 2012 Sample Fee List Members in any deductible plan 1 can use this list to help estimate their charges. NORTHERN CALIFORNIA As your partner in health, we want to help you manage your

More information

HER2-Targeted Rx. An Historical Perspective

HER2-Targeted Rx. An Historical Perspective HER2-Targeted Rx An Historical Perspective Trastuzumab: Front Line Rx for MBC Median 20.3 v. 25.1 mo P = 0.046 HR 0.8 65% of control patients crossed over Slamon D, et al. N Engl J Med, 2001; 344:783 Trastuzumab:Front-line

More information

Imaging Patient Education What you should know about your PET/CT Bone Scan.

Imaging Patient Education What you should know about your PET/CT Bone Scan. Imaging Patient Education What you should know about your PET/CT Bone Scan. Purpose: PET/CT uses a small amount of a radioactive sodium fluoride product to detect cancer within the bones. A low dose CT

More information

Kaiser Permanente 2013 Sample Fee List

Kaiser Permanente 2013 Sample Fee List Kaiser Permanente 2013 Sample Fee List Members in any deductible plan 1 can use this list to help estimate their charges. COLORADO As your partner in health, we want to help you manage your health care

More information

Breast Cancer. What is breast cancer?

Breast Cancer. What is breast cancer? Scan for mobile link. Breast Cancer Breast cancer is a malignant tumor in or around breast tissue. It usually begins as a lump or calcium deposit that develops from abnormal cell growth. Most breast lumps

More information

Cancer Program Report 2014

Cancer Program Report 2014 Cancer Program Report 2014 Queen of the Valley Hospital St Joseph Health Queen of the Valley Hospital - 2014 Site Table Site Total Class Sex Group Cases Analytic NonAn M F 0 I II ALL SITES 661 494 167

More information

Understanding Tumor Markers for Breast and Colorectal Cancers. A Patient s Guide. Recommendations of the American Society of Clinical Oncology

Understanding Tumor Markers for Breast and Colorectal Cancers. A Patient s Guide. Recommendations of the American Society of Clinical Oncology Cover Layout 1 A Patient s Guide Understanding Tumor Markers for Breast and Colorectal Cancers Recommendations of the American Society of Clinical Oncology ... Cover Layout 2 A Patient s Guide Understanding

More information

Monitoring Patients Undergoing Cancer Therapy. By Timothy K. Egan

Monitoring Patients Undergoing Cancer Therapy. By Timothy K. Egan F E A T U R E By Timothy K. Egan Before placement in a computed tomography scanner, a patient is fitted with an immobilization device. Immobilization ensures that the same area of the patient is scanned

More information

Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD

Breast Cancer Basics. Clinical Oncology for Public Health Professionals. Ben Ho Park, MD, PhD This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology

Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology BREAST CANCER 24 Breast Cancer Highlights from the 2009 Annual Meeting of the American Society of Clinical Oncology Edited by William J. Gradishar, MD Robert H. Lurie Comprehensive Cancer Center of Northwestern

More information

Subject ID: I N D # # U A * Consent Date: Day Month Year

Subject ID: I N D # # U A * Consent Date: Day Month Year IND Study # Eligibility Checklist Pg 1 of 15 Instructions: Check the appropriate box for each Inclusion and Exclusion Criterion below. Each criterion must be marked and all protocol criteria have to be

More information

Breast Cancer Scanning the Horizon

Breast Cancer Scanning the Horizon Breast Cancer Scanning the Horizon Prof Fran Boyle BCNA Summit Sydney 2013 Feature Interview: Dr Fran Boyle :: Sunday Nights - ABC www.abc.net.au/sundaynights/stories/s1544975.htm Familial breast cancer

More information

OUTLINE PAST PRESENTFUTURE BREAST CANCER INCIDENCE AND MORTALITY CURRENT STATE OF MEDICAL ONCOLOGY SECOND ANNUAL BREAST CANCER SYMPOSIUM

OUTLINE PAST PRESENTFUTURE BREAST CANCER INCIDENCE AND MORTALITY CURRENT STATE OF MEDICAL ONCOLOGY SECOND ANNUAL BREAST CANCER SYMPOSIUM OUTLINE CURRENT STATE OF MEDICAL ONCOLOGY SECOND ANNUAL BREAST CANCER SYMPOSIUM October 11, 2014 SARA M GARRIDO, M.D., F.A.C.P Chief Medical Officer at AMS Miami, October 11, 2014 PAST PRESENTFUTURE -BRIEF

More information

A breast lump or thickening that feels different from the surrounding tissue

A breast lump or thickening that feels different from the surrounding tissue Breast Cancer Breast cancer is caused by abnormal cells that form in the breast tissue. Breast cancer is the most common cancer affecting South African women 1 in 35 women in South Africa will be diagnosed

More information

Dates Reviewed: 12/2012, 3/2013, 6/2013, 9/2013, 11/2013, 12/2013, 3/2014, 6/2014, 9/2014, 12/2014,

Dates Reviewed: 12/2012, 3/2013, 6/2013, 9/2013, 11/2013, 12/2013, 3/2014, 6/2014, 9/2014, 12/2014, Perjeta (pertuzumab) Last Review Date: 5/30/2017 Date of Origin: 11/01/2012 Document Number: IC-0096 Dates Reviewed: 12/2012, 3/2013, 6/2013, 9/2013, 11/2013, 12/2013, 3/2014, 6/2014, 9/2014, 12/2014,

More information

CASE STUDIES CLINICAL CASE SCENARIOS. Matthew J. Ellis, MD, PhD

CASE STUDIES CLINICAL CASE SCENARIOS. Matthew J. Ellis, MD, PhD CLINICAL CASE SCENARIOS Matthew J. Ellis, MD, PhD Clinicians face daily challenges in the management of individual patients with breast cancer who demonstrate different characteristics in terms of estrogen

More information

Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation

Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss A Publication of The Bone and Cancer Foundation Contents This publication includes important information about

More information

Inflammatory breast cancer. This booklet describes what inflammatory breast cancer is, the symptoms, how it is diagnosed and how it may be treated.

Inflammatory breast cancer. This booklet describes what inflammatory breast cancer is, the symptoms, how it is diagnosed and how it may be treated. Inflammatory breast cancer This booklet describes what inflammatory breast cancer is, the symptoms, how it is diagnosed and how it may be treated. 2 Call our Helpline on 0808 800 6000 Introduction We hope

More information

Targeted Agents In Breast Cancer. Wonderful Music With New Instruments

Targeted Agents In Breast Cancer. Wonderful Music With New Instruments Targeted Agents In Breast Cancer Wonderful Music With New Instruments 1 Trends In Cancer Mortality In Women in US At This Rate We Will Beat Breast Cancer In 2040 Is the cause screening?? Is the cause better

More information

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast

Q&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast Collecting Cancer Data Breast NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar

More information

Breast Cancer Treatment at Fox Chase Make an Appointment or Request a Second Opinion FOX-CHASE

Breast Cancer Treatment at Fox Chase Make an Appointment or Request a Second Opinion FOX-CHASE Your Guide to Breast Cancer Treatment at Fox Chase Make an Appointment or Request a Second Opinion 1-888-FOX-CHASE Breast cancer will affect an estimated 232,340 Highlighted Bladder women and 2,240 men

More information

Early Detection, Diagnosis, and Staging of Ewing Tumors

Early Detection, Diagnosis, and Staging of Ewing Tumors Early Detection, Diagnosis, and Staging of Ewing Tumors Detection and Diagnosis Catching cancer early often allows for more treatment options. Some early cancers may have signs and symptoms that can be

More information

General Information Key Points

General Information Key Points The content of this booklet was adapted from content originally published by the National Cancer Institute. Male Breast Cancer Treatment (PDQ ) Patient Version. Updated September 29,2017. https://www.cancer.gov/types/breast/patient/male-breast-treatment-pdq

More information

Cancer. University of Illinois at Chicago College of Nursing

Cancer. University of Illinois at Chicago College of Nursing Cancer University of Illinois at Chicago College of Nursing 1 Learning Objectives Upon completion of this session, participants will be better able to: 1. Develop a basic understanding of cancer 2. Describe

More information

CHRONIC KIDNEY DISEASE WHY WOMEN MAY BE AT RISK?

CHRONIC KIDNEY DISEASE WHY WOMEN MAY BE AT RISK? CHRONIC KIDNEY DISEASE WHY WOMEN MAY BE AT RISK? Dr. Judy A Geissler, DNP, APNP, FNP-BC, CNN Vascular Access Advanced Practice Provider Employer- Medical College of Wisconsin No financial disclosures Barbara

More information

Your Guide to the Breast Cancer Pathology. Report. Key Questions. Here are important questions to be sure you understand, with your doctor s help:

Your Guide to the Breast Cancer Pathology. Report. Key Questions. Here are important questions to be sure you understand, with your doctor s help: Your Guide to the Breast Cancer Pathology Report Key Questions Here are important questions to be sure you understand, with your doctor s help: Your Guide to the Breast Cancer Pathology Report 1. Is this

More information

Monitoring Metastatic Breast Cancer with Serum HER-2/neu: Individual Patient Profiles

Monitoring Metastatic Breast Cancer with Serum HER-2/neu: Individual Patient Profiles Siemens Healthcare Diagnostics, a global leader in clinical diagnostics, provides healthcare professionals in hospital, reference, and physician office laboratories and point-of-care settings with the

More information

What Is Nuclear Medicine?

What Is Nuclear Medicine? What Is Nuclear Medicine? An Introductory Guide For Patients And Their Families What is nuclear medicine? Nuclear medicine is a type of medical imaging that uses small amounts of radioactive material (called

More information

Educator Navigation Guide

Educator Navigation Guide Decoding Breast Cancer Virtual Lab Educator Navigation Guide Decoding Cancer Nav Guide 2 Introduction In this virtual lab, students test tissue samples from different patients with breast cancer in order

More information

Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation

Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss. A Publication of The Bone and Cancer Foundation Questions and Answers About Breast Cancer, Bone Metastases, & Treatment-Related Bone Loss A Publication of The Bone and Cancer Foundation Contents This publication includes important information about

More information

Case 1: HER2 positive MBC. Sudeep Gupta Tata Memorial Centre

Case 1: HER2 positive MBC. Sudeep Gupta Tata Memorial Centre Case 1: HER2 positive MBC Sudeep Gupta Tata Memorial Centre 54/F, postmenopausal First came to TMC on 3/8/15 Diagnosed in Jan 2015 Right breast mass Bones (L5 & S1), lung, spleen (upfront MBC) IDC grade

More information

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined

Breast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Herceptin) Reference Number: ERX.SPA.42 Effective Date: 07.01.16 Last Review Date: 05/17 Line of Business: Commercial [Prescription Drug Plan] Revision Log See Important Reminder at the

More information

W3C Life Sciences: Clinical Observations Interoperability: EMR + Clinical Trials Use-case for EMR + Clinical Trials Interoperability

W3C Life Sciences: Clinical Observations Interoperability: EMR + Clinical Trials Use-case for EMR + Clinical Trials Interoperability W3C Life Sciences: Clinical Observations Interoperability: EMR + Clinical Trials Use-case for EMR + Clinical Trials Interoperability Background: The key issue is to investigate whether some of the data

More information

COME HOME Innovative Oncology Business Solutions, Inc.

COME HOME Innovative Oncology Business Solutions, Inc. Innovative Oncology Business Solutions, Inc. Breast Cancer Diagnostic/Therapeutic Pathway V11, April 2015 Required Structured Data Fields: ICD9 Code Stage Staging Components Performance Status Treatment

More information

Metastatic Breast Cancer What is new? Subtypes and variation?

Metastatic Breast Cancer What is new? Subtypes and variation? Metastatic Breast Cancer What is new? Subtypes and variation? Anne Blaes, MD, MS University of Minnesota, Division of Hematology/Oncology Director, Adult Cancer Survivor Program Current estimates for metastatic

More information

Breast Cancer. Saima Saeed MD

Breast Cancer. Saima Saeed MD Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast

More information

Molecular Imaging and Cancer

Molecular Imaging and Cancer Molecular Imaging and Cancer Cancer causes one in every four deaths in the United States, second only to heart disease. According to the U.S. Department of Health and Human Services, more than 512,000

More information

Statement from John delcharco, M.D., Frye Regional s Oncology Medical Director and Cancer Committee Chairman:

Statement from John delcharco, M.D., Frye Regional s Oncology Medical Director and Cancer Committee Chairman: Statement from John delcharco, M.D., Frye Regional s Oncology Medical Director and Cancer Committee Chairman: Enhancements and achievements for 2015-2017 include: Commission on Cancer (COC) accreditation

More information

Breast Cancer. What is breast cancer?

Breast Cancer. What is breast cancer? Scan for mobile link. Breast Cancer Breast cancer is a malignant tumor in or around breast tissue. It usually begins as a lump or calcium deposit that develops from abnormal cell growth. Most breast lumps

More information

Nuclear Medicine Bone Imaging

Nuclear Medicine Bone Imaging Nuclear Medicine Bone Imaging An Introductory Guide For Patients And Their Families You may be wondering why your doctor ordered a nuclear medicine bone scan. You might have questions such as: How does

More information

DEFINITION. Breast cancer is cancer that forms in the. more common in women.

DEFINITION. Breast cancer is cancer that forms in the. more common in women. BREAST CANCER DEFINITION Breast cancer is cancer that forms in the cells of the breasts. Breast cancer can occur in both men and women, but it's far more common in women. Normal Breast Tissue DEFINITION

More information

Expert Review The Role of Molecular Imaging in Response Prediction in Metastatic Breast Cancer

Expert Review The Role of Molecular Imaging in Response Prediction in Metastatic Breast Cancer Expert Review The Role of Molecular Imaging in Response Prediction in Metastatic Breast Cancer Geraldine Gebhart, MD Institut Jules Bordet Brussels, Belgium Discussants Moderator Lee Lokey, MD prime Oncology

More information

Barriers to Understanding

Barriers to Understanding Behind the Scenes: The Critical Importance of Cancer Cell Pathology and the Pathologist Sherry T. Emery, M.D., Chief of Pathology Northeast Health System Barriers to Understanding Questions for 2010 What

More information

A Step Forward in Cancer Patient Care:

A Step Forward in Cancer Patient Care: Hong Kong Pharmacy Conference 2018 A Step Forward in Cancer Patient Care: The Experience of Oncology Pharmacist-Managed Trastuzumab Clinic in Queen Mary Hospital Amy Yuen Clinical Pharmacist 24 Oct 2017.

More information

Navigators Lead the Way

Navigators Lead the Way RN Navigators Their Role in patients with Cancers of the GI tract Navigators Lead the Way Nurse Navigator Defined Nurse Navigator A clinically trained individual responsible for the identification and

More information

Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF)

Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF) Austin Radiological Association Nuclear Medicine Procedure PET SODIUM FLUORIDE BONE SCAN (F-18 NaF) Overview Indication Sodium Fluoride F18 injection is a radioactive diagnostic agent for positron emission

More information

Tykerb. Tykerb (lapatinib) Description

Tykerb. Tykerb (lapatinib) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Tykerb Page: 1 of 5 Last Review Date: June 24, 2016 Tykerb Description Tykerb (lapatinib) Background

More information

GASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS. HLC174A October Usha Nagavarapu Project Analyst

GASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS. HLC174A October Usha Nagavarapu Project Analyst GASTRIC CANCER TESTING, TREATMENT AND PREVENTION: TECHNOLOGIES AND GLOBAL MARKETS HLC174A October 2015 Usha Nagavarapu Project Analyst ISBN: 1-62296-167-6 BCC Research 49 Walnut Park, Building 2 Wellesley,

More information

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors Lars Stegger, Benjamin Noto Department of Nuclear Medicine University Hospital Münster, Germany Content From PET to

More information

National Center of Oncology - Yerevan, Armenia

National Center of Oncology - Yerevan, Armenia - Yerevan, Armenia General Information New breast cancer cases treated per year 450 Breast multidisciplinarity team members 13 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

Tykerb. Tykerb (lapatinib) Description

Tykerb. Tykerb (lapatinib) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.21.23 Subject: Tykerb Page: 1 of 5 Last Review Date: December 8, 2017 Tykerb Description Tykerb (lapatinib)

More information

Identification of the Risk Factors of Bone Metastatic among Breast Cancer Women in Al-Bashir Hospital

Identification of the Risk Factors of Bone Metastatic among Breast Cancer Women in Al-Bashir Hospital Advances in Breast Cancer Research, 2018, 7, 120-129 http://www.scirp.org/journal/abcr ISSN Online: 2168-1597 ISSN Print: 2168-1589 Identification of the Risk Factors of Bone Metastatic among Breast Cancer

More information

Presented by: Lillian Erdahl, MD

Presented by: Lillian Erdahl, MD Presented by: Lillian Erdahl, MD Learning Objectives What is Breast Cancer Types of Breast Cancer Risk Factors Warning Signs Diagnosis Treatment Options Prognosis What is Breast Cancer? A disease that

More information

Interactive Discussion of Part I CS Coding Instructions: Working the Cases

Interactive Discussion of Part I CS Coding Instructions: Working the Cases Interactive Discussion of Part I CS Coding Instructions: Working the Cases April Fritz, RHIT, CTR Donna M. Gress, RHIT, CTR Jennifer Ruhl, RHIT, CCS, CTR This presentation was supported by the Cooperative

More information

Breast Unit - University of Heidelberg - Heidelberg, Germany

Breast Unit - University of Heidelberg - Heidelberg, Germany - Heidelberg, Germany General Information New breast cancer cases treated per year 600 Breast multidisciplinarity team members 17 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

Pancreatic Cancer. What is pancreatic cancer?

Pancreatic Cancer. What is pancreatic cancer? Scan for mobile link. Pancreatic Cancer Pancreatic cancer is a tumor of the pancreas, an organ that is located behind the stomach in the abdomen. Pancreatic cancer does not always cause symptoms until

More information

We are gong to focus on: Unit 9. Before we begin: Chronic Renal Failure/Uremia ESRD/Dialysis Prostate Cancer Testicular Cancer Renal Cancer

We are gong to focus on: Unit 9. Before we begin: Chronic Renal Failure/Uremia ESRD/Dialysis Prostate Cancer Testicular Cancer Renal Cancer Unit 9 Problems with excretion Before we begin: You are to understand on your own: A & P of Renal System Common terms of renal system How to perform a focused health history How to perform a Physical Exam

More information

A Clinical Context Report

A Clinical Context Report Metastatic Breast Cancer in Practice An Expert Commentary with Carey Anders, MD A Clinical Context Report Clinical Context: Metastatic Breast Cancer in Practice Expert Commentary Jointly Sponsored by:

More information

Her 2 Positive Metastatic Breast Cancer

Her 2 Positive Metastatic Breast Cancer Her 2 Positive Metastatic Breast Cancer Alison Jones November 2013 Mrs Hermione Positive (then and now!) Diagnosed 2007 T2 N1 Mo ER ve; Her2 ve Mastectomy ANC; FEC/T Herceptin (12months) August 2010metastatic

More information

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure.

Lab Values Explained. working at full strength. Other possible causes of an elevated BUN include dehydration and heart failure. Patient Education Lab Values Explained Common Tests to Help Diagnose Kidney Disease Lab work, urine samples and other tests may be given as you undergo diagnosis and treatment for renal failure. The test

More information

Conducting Research Involving Medical Imaging

Conducting Research Involving Medical Imaging Conducting Research Involving Medical Imaging J. Keith Smith, MD, PhD Terry Hartman, MPH, MS, CCRC Angela Creighton, MBA April 19, 2018 Objectives Summarize the risks of medical imaging involving ionizing

More information

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET Positron Emission Tomography (PET) When calling Anthem (1-800-533-1120) or using the Point of Care authorization system for a Health Service Review, the following clinical information may be needed to

More information

Brain Tumors. What is a brain tumor?

Brain Tumors. What is a brain tumor? Scan for mobile link. Brain Tumors A brain tumor is a collection of abnormal cells that grows in or around the brain. It poses a risk to the healthy brain by either invading or destroying normal brain

More information

HER2 status assessment in breast cancer. Marc van de Vijver Academic Medical Centre (AMC), Amsterdam

HER2 status assessment in breast cancer. Marc van de Vijver Academic Medical Centre (AMC), Amsterdam HER2 status assessment in breast cancer Marc van de Vijver Academic Medical Centre (AMC), Amsterdam 13e Bossche Mamma Congres 17 th June 2015 Modern cancer therapies are based on sophisticated molecular

More information

Breast Cancer MultiDisciplinary Approach

Breast Cancer MultiDisciplinary Approach Breast Cancer MultiDisciplinary Approach October 30, 2012 Kristi Dolcetti RN, CON, CBPNC-IC OTN Bookings Regional Cancer Care is booking indirect Patient visits for our Multidisciplinary Cancer Conferences

More information

Her 2 Positive Advanced Breast Cancer: From Evidence to Practice

Her 2 Positive Advanced Breast Cancer: From Evidence to Practice Her 2 Positive Advanced Breast Cancer: From Evidence to Practice Sunil Verma MD, FRCP(C) Medical Director, Tom Baker Cancer Center Professor and Head, Department of Oncology Cumming School of Medicine,

More information

Abbreviated Breast MRI

Abbreviated Breast MRI ABBREVIATED MRI FOR BREAST CANCER SCREENING what you should know & how to prepare Abbreviated Breast MRI [ www.suburbanimaging.com ] What is Abbreviated Breast MRI? Abbreviated Breast MRI is an additional

More information

Fort McMurray Community Cancer Centre Patient Guide for Cancer Care

Fort McMurray Community Cancer Centre Patient Guide for Cancer Care Fort McMurray Community Cancer Centre Patient Guide for Cancer Care Northern Lights Regional Healthcare Centre 7 Hospital Street Fort McMurray, Alberta T9H 1P2 Main Desk: 780-791-6217 Cancer Patient Education

More information

FAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated

FAST FACTS Eligibility Reviewed and Verified By MD/DO/RN/LPN/CRA Date MD/DO/RN/LPN/CRA Date Consent Version Dated Page 1 of 5 COG-AEWS1221: Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly

More information

Nuclear Medicine in the Diabetic Foot

Nuclear Medicine in the Diabetic Foot 26.11.2015, Uniklinik Balgrist Nuclear Medicine in the Diabetic Foot Martin Hüllner Nuklearmedizin und Neuroradiologie, USZ / UZH Outline A. Imaging modalities brief technical overview B. Nuclear medicine

More information

Sutter Health Plus Effective for Calendar Year 2015

Sutter Health Plus Effective for Calendar Year 2015 Sutter Health Plus Effective for Calendar Year 2015 CPTs CPT Descriptions 2015 Cost Under Deducible (Single Unit) Doctor's Office Visit for a New Patient (Also Urgent Care) 99201 Low Level Visit $99.00

More information

Cork University Hospital - Cork, Ireland

Cork University Hospital - Cork, Ireland - Cork, Ireland General Information New breast cancer cases treated per year 336 Breast multidisciplinarity team members 25 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists and

More information

PATIENT INSTRUCTION. Extensive myocardial metabolic PET/CT NUCLEAR MEDICINE. Appointment time. Preparation for examination

PATIENT INSTRUCTION. Extensive myocardial metabolic PET/CT NUCLEAR MEDICINE. Appointment time. Preparation for examination Extensive myocardial metabolic PET/CT Appointment time You have been scheduled for PET-CT scan. The appointment will take 2-4 hours, of which part will be spent in bed rest. Imaging time is about 30 minutes.

More information

3/9/2017. Chapter 56. Care of the Patient with Cancer. Cancer Rates in the US. Carcinogenesis

3/9/2017. Chapter 56. Care of the Patient with Cancer. Cancer Rates in the US. Carcinogenesis Chapter 56 Care of the Patient with Cancer All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Cancer Rates in the US 1 in 2 men and 1 in 3 women

More information

Groote Schuur Academic Hospital - Cape Town, South Africa

Groote Schuur Academic Hospital - Cape Town, South Africa - Cape Town, South Africa General Information New breast cancer cases treated per year 400 Breast multidisciplinarity team members 7 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information

Positron Emission Tomography Computed Tomography (PET/CT)

Positron Emission Tomography Computed Tomography (PET/CT) Positron Emission Tomography Computed Tomography (PET/CT) What is Positron Emission Tomography Computed Tomography (PET/CT) Scanning? What are some common uses of the procedure? How should I prepare for

More information

Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients

Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients Breast Cancer (2013) 20:336 341 DOI 10.1007/s12282-012-0341-6 ORIGINAL ARTICLE Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients Rikiya Nakamura Naohito Yamamoto

More information

Molecular Imaging and Breast Cancer

Molecular Imaging and Breast Cancer Molecular Imaging and Breast Cancer Breast cancer forms in tissues of the breast usually in the ducts, tubes that carry milk to the nipple, and lobules, the glands that make milk. It occurs in both men

More information

Cancer , The Patient Education Institute, Inc. ocf80101 Last reviewed: 06/08/2016 1

Cancer , The Patient Education Institute, Inc.   ocf80101 Last reviewed: 06/08/2016 1 Cancer Introduction Cancer begins in your cells, which are the building blocks of your body. Extra cells can form a mass called a tumor. Some tumors aren t cancerous, while other ones are. Cells from cancerous

More information

Screening Mammograms: Questions and Answers

Screening Mammograms: Questions and Answers CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Screening Mammograms:

More information

Cell Biology and Cancer

Cell Biology and Cancer Name: Cell Biology and Cancer Date: Questions 1. BRCA1 and BRCA2 are what types of genes? 2. List two ways that cancerous and healthy cells differ. 3. Which organelle makes proteins? 4. At what phase of

More information

Cases presented with teleradiology and telepathology by the local team

Cases presented with teleradiology and telepathology by the local team Cases presented with teleradiology and telepathology by the local team W. Demey (oncology), P. Van Dam (surgery), I. Biltjes (radiology), P. Dirix (radiation oncology), C. Colpaert (pathology) 1 Case 1:

More information

Original Article Continuous trastuzumab treatment for more than 9 years of metastatic breast cancer without cardiotoxicity: a case report

Original Article Continuous trastuzumab treatment for more than 9 years of metastatic breast cancer without cardiotoxicity: a case report Int J Clin Exp Med 2019;12(2):1803-1807 www.ijcem.com /ISSN:1940-5901/IJCEM0077045 Original Article Continuous trastuzumab treatment for more than 9 years of metastatic breast cancer without cardiotoxicity:

More information

Pros and Cons from the Patient Perspective in the Three Phases

Pros and Cons from the Patient Perspective in the Three Phases Pros and Cons from the Patient Perspective in the Three Phases Wanda M. Burdette, RN, OCN, CCRP Spartanburg Regional Medical Center SCOR NCORP November 6, 2015 12:00-2:00 PM CT Presentation Objectives

More information

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC

Cancers of unknown primary : Knowing the unknown. Prof. Ahmed Hossain Professor of Medicine SSMC Cancers of unknown primary : Knowing the unknown Prof. Ahmed Hossain Professor of Medicine SSMC Definition Cancers of unknown primary site (CUPs) Represent a heterogeneous group of metastatic tumours,

More information

Systemic Treatment of Breast Cancer. Hormone Therapy and Chemotherapy, Curative and Palliative

Systemic Treatment of Breast Cancer. Hormone Therapy and Chemotherapy, Curative and Palliative Systemic Treatment of Breast Cancer Hormone Therapy and Chemotherapy, Curative and Palliative Systemic Therapy Invasive breast cancers Two forms Curative Palliative Curative Systemic Therapy Adjuvant Therapy

More information

University Clinical Center Banja Luka, Breast Center - Banja Luka, Bosnia and Herzegovina

University Clinical Center Banja Luka, Breast Center - Banja Luka, Bosnia and Herzegovina - Banja Luka, Bosnia and Herzegovina General Information New breast cancer cases treated per year 245 Breast multidisciplinarity team members 23 Radiologists, surgeons, pathologists, medical oncologists,

More information

Open Clinical Trials: What s Out There Now Paula D. Ryan, MD, PhD

Open Clinical Trials: What s Out There Now Paula D. Ryan, MD, PhD Open Clinical Trials: What s Out There Now Paula D. Ryan, MD, PhD Hanahan and Weinberg, 2000 Acquired Capabilities of Cancer Clinical Trials When should I consider a clinical trial? How do I find the right

More information

Pathology Report Patient Companion Guide

Pathology Report Patient Companion Guide Pathology Report Patient Companion Guide Breast Cancer - Understanding Your Pathology Report Pathology Reports can be overwhelming. They contain scientific terms that are unfamiliar and might be a bit

More information

Review of adjuvant and neo-adjuvant abstracts from SABCS 2011 January 7 th 2012

Review of adjuvant and neo-adjuvant abstracts from SABCS 2011 January 7 th 2012 Review of adjuvant and neo-adjuvant abstracts from SABCS 2011 January 7 th 2012 Ruth M. O Regan, MD Professor and Vice-Chair for Educational Affairs, Department of Hematology and Medical Oncology, Emory

More information

Visual Guide To Breast Cancer

Visual Guide To Breast Cancer Breast Cancer Today Breast cancer today is not what it was 20 years ago. Survival rates are climbing, thanks to greater awareness, more early detection, and advances in treatment. For roughly 200,000 Americans

More information

Barlavento Medical Centre - Portimão, Portugal

Barlavento Medical Centre - Portimão, Portugal - Portimão, Portugal General Information New breast cancer cases treated per year 150 Breast multidisciplinarity team members 9 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists

More information